UY31988A - PIRIMIDINILSULFONAMIDE COMPOUNDS FOR USE IN THE TREATMENT OF A CHEMIOCINE-MEDIUM DISEASE - Google Patents

PIRIMIDINILSULFONAMIDE COMPOUNDS FOR USE IN THE TREATMENT OF A CHEMIOCINE-MEDIUM DISEASE

Info

Publication number
UY31988A
UY31988A UY31988A UY31988A UY31988A UY 31988 A UY31988 A UY 31988A UY 31988 A UY31988 A UY 31988A UY 31988 A UY31988 A UY 31988A UY 31988 A UY31988 A UY 31988A
Authority
UY
Uruguay
Prior art keywords
treatment
pirimidinilsulfonamide
chemiocine
compounds
medium disease
Prior art date
Application number
UY31988A
Other languages
Spanish (es)
Inventor
Andrew James Robins
Jeffrey Paul Stonehouse
Meghani Premhi
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to UY31988A priority Critical patent/UY31988A/en
Publication of UY31988A publication Critical patent/UY31988A/en

Links

Abstract

Un compuesto de fórmula (1) y sales farmacéuticamente aceptables de este para usar en el tratamiento de enfermedades y afecciones mediadas por quimiocina.A compound of formula (1) and pharmaceutically acceptable salts thereof for use in the treatment of chemokine-mediated diseases and conditions.

UY31988A 2009-07-15 2009-07-15 PIRIMIDINILSULFONAMIDE COMPOUNDS FOR USE IN THE TREATMENT OF A CHEMIOCINE-MEDIUM DISEASE UY31988A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY31988A UY31988A (en) 2009-07-15 2009-07-15 PIRIMIDINILSULFONAMIDE COMPOUNDS FOR USE IN THE TREATMENT OF A CHEMIOCINE-MEDIUM DISEASE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY31988A UY31988A (en) 2009-07-15 2009-07-15 PIRIMIDINILSULFONAMIDE COMPOUNDS FOR USE IN THE TREATMENT OF A CHEMIOCINE-MEDIUM DISEASE

Publications (1)

Publication Number Publication Date
UY31988A true UY31988A (en) 2010-02-26

Family

ID=43447909

Family Applications (1)

Application Number Title Priority Date Filing Date
UY31988A UY31988A (en) 2009-07-15 2009-07-15 PIRIMIDINILSULFONAMIDE COMPOUNDS FOR USE IN THE TREATMENT OF A CHEMIOCINE-MEDIUM DISEASE

Country Status (1)

Country Link
UY (1) UY31988A (en)

Similar Documents

Publication Publication Date Title
CY2020032I1 (en) PLEUROMUTILIN DERIVATIVES FOR THE TREATMENT OF DISEASES CAUSED BY MICROBES
CL2012001911A1 (en) Compounds derived from fumarate; pharmaceutical composition comprising them; and its use in the treatment of an inflammatory or neurodegenerative disease.
CY1118340T1 (en) MOVEMENT SUSPENSIONS
GT200500360A (en) ORGANIC COMPOUNDS
CR20150628A (en) DERIVATIVES OF PIRAZOLOPIRROLIDINE AND ITS USE IN THE TREATMENT OF DISEASES
UY30809A1 (en) DERIVATIVES OF N- [3- [4-PHENYL) PIPERIDIN-1-CARBONIL] PHENYL] SUBSTITUTED SULFONAMIDS, PREPARATION PROCESSES AND APPLICATIONS
TW201000473A (en) Benzene or thiophene derivative and use thereof as VAP-1 inhibitor
ECSP099436A (en) ACILAMINOPIRAZOLES AS FGFR INHIBITORS
ATE511392T1 (en) DELAYED-RELEASE ORAL DOSAGE FORMS OF A PRODRUG OF R-BACLOFEN AND METHODS OF TREATMENT THEREOF
PE20151542A1 (en) TETRAHYDROPYRROTHIAZINE COMPOUNDS
MX2015016344A (en) Imidazopyrrolidinone derivatives and their use in the treatment of disease.
CO6480932A2 (en) ANTAGONISTS OF THE HEDGEHOG TRAJECTORY OF DISTTITUTED FTALAZINA.
CL2008002542A1 (en) Imidazolyl pyridine derived compounds linked to a heterocycle via a vinyl, modulators of amyloid-beta activity; pharmaceutical composition comprising said compounds; and its use for the treatment of diseases such as Alzheimer's, dementia, Down syndrome or amyloidosis.
UY32535A (en) METHODS AND INTERMEDIARIES FOR THE PREPARATION OF PHARMACEUTICAL AGENTS
CO6491060A2 (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITARY DISEASES
CO6321285A2 (en) USE OF 3,11B-CIS- DIHIDROTETRABENAZINE IN THE TREATMENT OF MULTIPLE SCLEROSIS AND SELF-IMMUNE HONEY MIELITIS
AR062394A1 (en) USE OF COMPOUNDS AND DERIVATIVES OF 2,5-DIHYDROXIBENCEN FOR THE TREATMENT OF PSORIASIS
MX2010008460A (en) Thiazole derivative and use thereof as vap-1 inhibitor.
CR20120084A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER AND OTHER DISEASES OR DISORDERS
AR062390A1 (en) USE OF DERIVATIVES OF 2,5-DIHYDROXIBENGEN FOR THE TREATMENT OF HEMANGIOMS OR HEMANGIOBLASTOMAS
ECSP088700A (en) 4-PHENYL-TIAZOL-5-CARBOXILIC ACIDS AND 4-PHENYL-TIAZOL-5-CARBOXILIC ACIDS AS INHIBITORS OF THE PLK1
CO6480931A2 (en) HETEROCYCLIC SULFONAMIDS, USES AND PHARMACEUTICAL COMPOSITIONS OF THE SAME.
CO6361988A2 (en) CRYSTAL FORM OF A COMPOUND OF 4- [2- (2-FLUOROPHENOXIMETHYL) PHENYL] PIPERIDINE.
AR062401A1 (en) USE OF DERIVATIVES OF 2,5-DIHYDROXIBENCEN TO TREAT DERMATITIS
CO6321280A2 (en) NEW ESPIRO PIPERIDINAS CLASS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20181108